Scarica l'app Stockscreener
7.56
6.93%
0.49
Precedente Chiudi:
$7.07
Aprire:
$6.68
Volume 24 ore:
123.34K
Relative Volume:
0.58
Capitalizzazione di mercato:
$708.81M
Reddito:
$106.66M
Utile/perdita netta:
$15.16M
Rapporto P/E:
80.86
EPS:
0.0935
Flusso di cassa netto:
$6.37M
1 W Prestazione:
+9.25%
1M Prestazione:
+0.93%
6M Prestazione:
-34.94%
1 anno Prestazione:
-29.15%
Intervallo 1D:
$6.62
$7.66
Intervallo di 1 settimana:
$6.62
$7.66
Portata 52W:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Nome
Gyre Therapeutics Inc
Settore
Industria
Telefono
(619) 949-3681
Indirizzo
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Confronta GYRE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.56 | 640.94M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-11 | Iniziato | Noble Capital Markets | Outperform |
| 2021-04-29 | Ripresa | Stephens | Overweight |
| 2021-02-10 | Iniziato | Piper Sandler | Overweight |
| 2020-05-21 | Iniziato | Raymond James | Outperform |
| 2019-01-04 | Iniziato | Oppenheimer | Outperform |
| 2018-02-12 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Reiterato | Chardan Capital Markets | Buy |
| 2017-12-08 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Iniziato | Chardan Capital Markets | Buy |
| 2017-06-06 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-06-30 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Gyre Therapeutics Inc Borsa (GYRE) Ultime notizie
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down on Disappointing Earnings - Defense World
Gyre Therapeutics Inc. stock trend outlook and recovery pathWatchlist Summary for Active Day Traders - Newser
Using AI based signals to follow Gyre Therapeutics Inc.Expert-Backed High Yield Stock Watchlist - Newser
News impact scoring models applied to Gyre Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
Using RSI to spot recovery in Gyre Therapeutics Inc.Long-Term Allocation Strategy Summary Breakdown - Newser
Gyre Therapeutics Reports Q2 2025 Earnings and Strategic Updates - TipRanks
Gyre Therapeutics Misses Estimates And Swaps In A New CEO - Finimize
GYRE THERAPEUTICS, INC. SEC 10-Q Report - TradingView
Can you recover from losses in Gyre Therapeutics Inc.Free Reliable Investment Entry Point Signals - Newser
Gyre Therapeutics' Q2 revenue misses estimates - MarketScreener
Gyre Therapeutics Hits Major Milestone: Phase 3 Liver Drug Success Powers $128M Revenue Outlook - Stock Titan
Sector Rotation Brings Gyre Therapeutics Inc. Into FocusTriple Return Setup With Risk Control Explained - beatles.ru
Published on: 2025-08-11 05:27:12 - Newser
Understanding Gyre Therapeutics Inc.’s price movementFree Trade Setups With AI Powered Filters - Newser
Why Gyre Therapeutics Inc. stock attracts strong analyst attentionReal-Time Entry Signals for Top Stocks - Newser
Published on: 2025-08-10 23:59:25 - Newser
What makes Gyre Therapeutics Inc. stock price move sharplyWeekly Market Direction and Sector Summary - Newser
When is the best time to exit Gyre Therapeutics Inc.Free Fundamental Growth Stock Analysis - Newser
How to use a screener to detect Gyre Therapeutics Inc. breakoutsInsider Strategy for High Conviction Picks - Newser
Price momentum metrics for Gyre Therapeutics Inc. explainedFundamental + Technical Combined Watchlist - Newser
Gyre Therapeutics (GYRE) Projected to Post Earnings on Tuesday - Defense World
Candlestick signals on Gyre Therapeutics Inc. stock todayTrend Confirmation Scanner with Entry Focus - Newser
Regression analysis insights on Gyre Therapeutics Inc. performanceHigh Accuracy Trade Setup Identification - Newser
Bank of New York Mellon Corp Buys 2,596 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Earnings visualization tools for Gyre Therapeutics Inc.Weekly Outlook for Short Term Investors - Newser
How hedge fund analytics apply to Gyre Therapeutics Inc. stockEntry Timing Tracker with Alert Accuracy - Newser
How institutional ownership impacts Gyre Therapeutics Inc. stockEquity Portfolio Outlook and Performance Summary - Newser
Gyre Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Daily Top Performing Stock Insights - Newser
Using flow based indicators on Gyre Therapeutics Inc.AI Generated Momentum Stock Forecast Guide - Newser
Gyre Therapeutics Inc. Breakout Confirmed by Volume MetricsStock Market Entry Timing Signals Revealed - metal.it
Should I hold or sell Gyre Therapeutics Inc. stock in 2025Get insider insights into market trends - Jammu Links News
What institutional investors are buying Gyre Therapeutics Inc. stockBreakthrough wealth creation - Jammu Links News
Is Gyre Therapeutics Inc. a good long term investmentMaximize your portfolio’s earning power - Jammu Links News
How volatile is Gyre Therapeutics Inc. stock compared to the marketExceptional profit velocity - Jammu Links News
Is Gyre Therapeutics Inc. stock overvalued or undervaluedUnmatched market gains - Jammu Links News
Why is Gyre Therapeutics Inc. stock attracting strong analyst attentionBuild wealth steadily with proven investment strategies - Jammu Links News
Gyre Therapeutics Inc Azioni (GYRE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):